🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Cadonilimab and Lenvatinib

Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma NCT06215651Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Cadonilimab lenvatinib A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma NCT06371157Phase 34 sites📍 Zhengzhou📍 Changsha📍 Nanjing Akeso · Tests: AK104, Lenvatinib, TACE, Placebo for AK104, Placebo for Lenvatinib Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma NCT06406634Phase 21 site📍 Changsha Hunan Cancer Hospital · Tests: Cadonilimab, Lenvatinib HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma NCT06187961Phase 21 site📍 Wuhan Tongji Hospital · Tests: Hepatic arterial infusion chemotherapy (HAIC-FOLFOX), Lenvatinib, Cadonilimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy